Mental Disorder
211
27
42
107
Key Insights
Highlights
Success Rate
96% trial completion (above average)
Published Results
23 trials with published results (11%)
Research Maturity
107 completed trials (51% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
2.4%
5 terminated out of 211 trials
95.5%
+9.0% vs benchmark
3%
6 trials in Phase 3/4
21%
23 of 107 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 107 completed trials
Clinical Trials (211)
Association Between Cardiovascular Diseases and Mental Illness
Improving Cognition of Older Adults in Community Housing
Study on the Effectiveness of Journaling as an add-on to Cognitive Behavioral Therapy
Virtual Menstrual Pain Approaches in Females
Psilocybin for the Treatment of Veterans With Post-Traumatic Stress Disorder
Preliminary Efficacy Trial of a Digital Intervention for Depression and Cannabis Use
Community Reinforcement and Family Training for Early Psychosis (CRAFT-EP) and Substance Use: A Pilot Study
Brain Stimulation to the Hippocampus in Schizophrenia
Search for Novel Transcranial Magnetic Stimulation (TMS) Targets for Mental Illness
Effect of Early Assessment Team for Patients Referred to Outpatient Mental Health Care
Improving Social Functioning in People With Substance Use and Mental Health Disorders Using VR
Self-Care for Dementia Caregivers
Assessment and Evolution of Narrative Identity and Its Relationship to Subjective Multidimensional Well-being and Multidimensional Recovery in First Episode Psychosis
Systems Aligning for Equity (SAFE) Spaces
Effect of Longitudinal Care in Primary Health Care: An Analysis From the Patient's Perspective
A Phone-call With a Student/General Practitioner Team to Impact Morbidity of Chronic Patients During COVID-19 Containment
Peer-based Recovery Program
Going to Altitude With Anxious-depressive Symptoms
Validation of a VOICE MAnagement Program in Schizophrenia VVoice MAPS
Passive Sensor Identification of Digital Biomarkers to Assess Effects of Orally Administered Nicotinamide Riboside